SOD3 and atopic conjunctivitis: Attenuation of the disease phenotype accompanied by a IgG2b-biased shift of immunoglobulins has also been reported in models of allergic conjunctivitis testing the therapeutic effectiveness of either superoxide dismutase 3 (34) or rapamycin (35).